Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands.
Fabian KrutzekCornelius K DonatSven StadlbauerPublished in: EJNMMI radiopharmacy and chemistry (2024)
Cu]Cu-14 exhibited favorable renal clearance; however, the limited uptake in tumors suggests the need for structural modifications to the binding motif for future PD-L1 radiotracers.